A case report on Transthyretin Cardiac Amyloidosis
G. Ziani, H. Souilk, R. El Azouzi, A. Ameur, N. Doghmi, M. Cherti
International Journal of Medical and Pharmaceutical Case Reports · pp. 52–58 · Published 27 Apr 2024
10.9734/ijmpcr/2024/v17i2376Abstract
Introduction : Cardiac amyloidosis is due to the extracellular accumulation of insoluble fibrillar proteins which progressively alter the function of the myocardium. The prognosis depends on the severity of the cardiac involvement. Transthyretin cardiac amyloidosis (TTR) is the most common. It can be wild-type (ATTRwt), hereditary (ATTRv) or senile (wild TTR). The diagnosis of cardiac amyloidosis has greatly improved in the last decade and is based on multimodal imaging, mainly echocardiography and bone scintigraphy. Case Report: We report the case of a male patient hospitalized for heart failure due to transthyretin cardiac amyloidosis. Conclusion: Recognition of this pathology is essential because cardiological management is specific and conventional treatments for heart failure can be harmful. Only specific treatments can slow down or stop the infiltration process.
References (13)
- 1 Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis [DOI]
- 2 Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness [DOI]
- 3 Transthyretin Cardiac Amyloidosis: An Update on Diagnosis and Treatment [DOI]
- 4 Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS) [DOI]
- 5 Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy [DOI]
- 6 Echocardiographic and Clinical Predictors of Cardiac Amyloidosis: Limitations of Apical Sparing [DOI]
- 7 Cardiac Amyloidosis Treatment [DOI]
- 8 Amyloidosis from the patient perspective: the French daily impact of amyloidosis study [DOI]
- 9 History of Extracardiac/Cardiac Events in Cardiac Amyloidosis: Prevalence and Time from Initial Onset to Diagnosis [DOI]
- 10 Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survival [DOI]
- 11 Electrical Cardioversion of Atrial Arrhythmias with Cardiac Amyloidosis in the Era of Direct Oral Anticogulants [DOI]
- 12 Real-Life Evaluation of an Algorithm for the Diagnosis of Cardiac Amyloidosis [DOI]
- 13 Transthyretin cardiac amyloidosis. [DOI]
Cited by 0
No indexed citations yet.
Related research
- Reducing Radiation Exposure in Diagnostic Imaging: The Case for Lead-Protective PPE — shares topic coverage
- Patient Awareness and Knowledge Level for Radiation in Different Radiology Modalities in Hospitals — shares topic coverage
- Abnormal Coronary-bronchial Fistula: The Role of Coronary CT Angiography — shares topic coverage
- Endodontic–periodontal Lesions Reconsidered: A Critical Appraisal of Pathogenetic Models, Diagnostic Uncertainty and Treatment Sequencing — shares topic coverage
- Diagnostic Accuracy and Cost-Effectiveness of Magnetic Resonance Imaging Versus Ultrasonography in Rotator Cuff Tears: A Critical Narrative Review — shares topic coverage
Article metrics
Real usage data collected on this platform.
32
Page views
0
PDF downloads
10
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.